PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 21, 2024Leukemia37 citationsOpen Access

Impaired binding affinity of YTHDC1 with METTL3/METTL14 results in R-loop accumulation in myelodysplastic neoplasms with DDX41 mutation

View Full Paper
WHWon Chan HwangKPKibeom ParkSPSilvia Park

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract DEAD box helicase 41 (DDX41) mutations are the most prevalent predisposition to familial myelodysplastic syndrome (MDS). However, the precise roles of these variants in the pathogenesis of MDS have yet to be elucidated. Here, we discovered a novel mechanism by which DDX41 contributes to R-loop-induced DNA damage responses (DDR) in cooperation with the m6A-METTL complex (MAC) and YTHDC1 using DDX41 knockout (KO) and DDX41 knock-in (KI, R525H, Y259C) cell lines as well as primary samples from MDS patients. Compared to wild type (WT), DDX41 KO and KI led to increased levels of m6A RNA methylated R-loop. Interestingly, we found that DDX41 regulates m6A/R-loop levels by interacting with MAC components. Further, DDX41 promoted the recruitment of YTHDC1 to R-loops by promoting the binding between METTL3 and YTHDC1, which was dysregulated in DDX41 -deficient cells, contributing to genomic instability. Collectively, we demonstrated that DDX41 plays a key role in the physiological control of R-loops in cooperation with MAC and YTHDC1. These findings provide novel insights into how defects in DDX41 influence MDS pathogenesis and suggest potential therapeutic targets for the treatment of MDS.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hwang et al. (2024) studied this question.

synapsesocial.com/papers/68e72f63b6db6435876a9258https://doi.org/10.1038/s41375-024-02228-4
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells2017 · 1,336 citations
  2. 2A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome Stability2009 · 576 citations
  3. 3A birds'‐eye view of the activity and specificity of the mRNA m6A methyltransferase complex2020 · 71 citations
  4. 4Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data2021 · 25 citations
  5. 5Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia2021 · 96 citations